Precision oncology with selective RET inhibitor selpercatinib in RET-rearranged cancers

Gouda, MA; Subbiah, V

Subbiah, V (通讯作者),Sarah Cannon Res Inst, 1100 Dr Martin L King Jr Blvd, Blvd Suite 800, Nashville, TN 37203 USA.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023; 15 ():

Abstract

Rearranged during transfection (RET) is a protooncogene that encodes for receptor tyrosine kinase with downstream effects on multiple cellular pathway......

Full Text Link